Efficacy and Safety of Fractional CO2 Laser Combined With Intralesional Insulin, Botulinum Toxin or Triamcinolone Acetonide in the Treatment of Keloid: A Clinical, Dermoscopic and Immunohistochemical Study.
Conditions: Keloid Interventions: Drug: Insulin group; Drug: Botulinum toxin group; Drug: Triamcinolone acetonide group Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials
Closed-loop Insulin Delivery Systems in Pancreatic Diabetes
Conditions: Secondary Pancreatic Diabetes Interventions: Device: hybrid closed loop insulin delivery system Sponsors: Centre Hospitalier Sud Francilien Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
Closed-loop Insulin Delivery Systems ( " Artificial Pancreas " ) in Patients With Pancreatitis or Pancreatectomy-induced Diabetes
Conditions: Secondary Pancreatic Diabetes Interventions: Device: hybrid closed loop Sponsors: Centre Hospitalier Sud Francilien Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
Effect of Cryolipolysis on Insulin Resistance
Conditions: Type 2 Diabetes Mellitus in Obese; Cryotherapy Effect Interventions: Procedure: Cryolipolysis Sponsors: Cairo University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Comparing the Effects of Different Types of Exercise on Glucose Handling
Conditions: Glycemic Control; Insulin Sensitivity; Sex Differences Interventions: Other: Control Oral Glucose Tolerance Test; Other: Mixed Exercise Sponsors: University of Waterloo Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
Effect of Pulsatile Hormone Administration on Insulin Action
Conditions: Insulin Sensitivity Interventions: Other: Continuous Insulin administration during hyperinsulinemic euglycemic clamp test; Other: Pulsatile Insulin administration during hyperinsulinemic euglycemic clamp test Sponsors: Pennington Biomedical Research Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
Transition of T1DM Patients Aged Over 65 Years Into AHCL (780G) Insulin Pump
Conditions: Diabetes Type 1 Interventions: Device: MiniMed 780G system Sponsors: Jagiellonian University; Medtronic Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
Feasibility Trial Using an Inpatient Insulin Doing Calculator
Conditions: Diabetes Mellitus, Type 2 Interventions: Other: Initial insulin dosing using the calculator Sponsors: University of Washington; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2024 Category: Research Source Type: clinical trials
The G Protein-Coupled Receptor Kinase Type 2 Inhibitor Paroxetine as Adjunctive Therapy to Improve Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: Paroxetine; Drug: Placebo Sponsors: aya ramadan ashmawy sarhan Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials
A Trial Comparing the Efficacy and Safety of GZR4 Injection Versus Insulin Degludec in Subjects With T2DM
Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: GZR4 Injection; Drug: Insulin Degludec Sponsors: Gan and Lee Pharmaceuticals, USA Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
A Trial Comparing Efficacy and Safety of GZR101 and IDegAsp in Insulin Na ïve or Insulin Treated Subjects With T2DM
Conditions: Type 2 Diabetes Interventions: Drug: GZR101; Drug: insulin degledec/insulin aspart Sponsors: Gan and Lee Pharmaceuticals, USA Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
Overfeeding Induced Fat-tissue Stimulation
Conditions: Lipid-induced Insulin Resistance Interventions: Behavioral: High-fat overnutrition; Behavioral: Normocaloric macronutrient-balanced nutrition Sponsors: German Diabetes Center; Yale University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
Benefit of Using Smart Connected Insulin Pens in Dependent Patients With Diabetes Using Continuous Glucose Measurement
Conditions: Diabetes Interventions: Behavioral: Counseling home caregivers Sponsors: Centre Hospitalier Sud Francilien Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
The Intelligent Diabetes TelemonitoRing Using Decision Support to Treat Patients on Insulin Therapy
Conditions: Type 2 Diabetes Treated With Insulin Interventions: Device: Intelligent telemonitoring; Device: Telemonitoring Sponsors: Aalborg University Hospital; Novo Nordisk A/S; DexCom, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety Between Different Dilution of Insulin
Conditions: Insulin Diluent for Better Blood Sugar Control Interventions: Drug: Gelafundin Sponsors: Universiti Sains Malaysia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2023 Category: Research Source Type: clinical trials
